Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harvey Walsh is a specialist healthcare data analytics and market access consultancy based in the United Kingdom. The company provides real-world evidence (RWE) and informatics solutions to the pharmaceutical and life sciences industries, helping clients demonstrate the value of their products through data-driven insights. Their services include patient pathway analysis, budget impact modeling, and the development of bespoke data visualization tools. In 2017, Harvey Walsh was acquired by OPEN Health, integrating its data capabilities into a broader global healthcare communications and market access group. The company is well-regarded for its ability to navigate complex healthcare datasets to support clinical and commercial decision-making.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harvey Walsh.